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Abstract
Background
We recently reported a novel observation that many patients with equal resting supine right
ventricular(RV) and pulmonary artery(PA) systolic pressures develop an RV outflow tract
(RVOT) pressure gradient during upright exercise. The current work details the characteris-
tics of patients who develop such an RVOT gradient.
Methods
We studied 294 patients (59.7±15.5 years-old, 49% male) referred for clinical invasive car-
diopulmonary exercise testing, who did not have a resting RVOT pressure gradient defined
by the simultaneously measured peak-to-peak difference between RV and PA systolic
pressures.
Results
The magnitude of RVOT gradient did not correspond to clinical or hemodynamic findings
suggestive of right heart failure; rather, higher gradients were associated with favorable
exercise findings. The presence of a high peak RVOT gradient (90th percentile,33mmHg)
was associated with male sex (70 vs. 46%, p = 0.01), younger age (43.6±17.7 vs. 61.8±13.9
years, p<0.001), lower peak right atrial pressure (5 [3–7] vs. 8 [4–12]mmHg, p<0.001),
higher peak heart rate (159±19 vs. 124±26 beats per minute, p<0.001), and higher peak car-
diac index (8.3±2.3 vs. 5.7±1.9 L/min/m2, p<0.001). These associations persisted when
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treating peak RVOT as a continuous variable and after age and sex adjustment. At peak
exercise, patients with a high exercise RVOT gradient had both higher RV systolic pressure
(78±11 vs. 66±17 mmHg, p<0.001) and lower PA systolic pressure (34±8 vs. 50±19 mmHg,
p<0.001).
Conclusions
Development of a systolic RV-PA pressure gradient during upright exercise is not associ-
ated with an adverse hemodynamic exercise response and may represent a normal physio-
logic finding in aerobically fit young people.
Introduction
Fixed right ventricular outflow (RVOT) obstruction, such as seen with pulmonary valve steno-
sis, causes a systolic pressure gradient between the right ventricle (RV) and pulmonary artery
(PA). Clinically significant dynamic RVOT obstruction is thought to be uncommon, but has
been described in a subset of patients after cardiac surgery or after lung transplantation [1–3].
RVOT obstruction can cause right heart failure, though mild or moderate degrees of obstruc-
tion are often clinically well tolerated. Even in the face of adequate compensation, however,
the presence of a pressure difference between the RV and PA during systole confounds echo-
cardiographic estimation of PA pressures based on tricuspid regurgitation flow velocity using
the simplified Bernoulli equation, which assumes RV and PA pressures are equal [4]. This is
important, since echocardiographic assessment of pulmonary hemodynamics during exercise
is an increasingly common and accepted part of clinical practice [5–9], particularly in specific
patient subsets such as congenital heart disease and rheumatologic disease [10–15].
Dynamic left ventricular outflow tract obstruction has been extensively investigated, mainly
in the context of hypertrophic cardiomyopathy [16], but this phenomenon can also occur with
reduced preload [17, 18], increased contractility [19] and Takotsubo cardiomyopathy [20].
Considered anatomically, the RVOT would seem more susceptible to dynamic muscular
obstruction given the presence of a circumferential, muscular, contractile infundibulum in
contrast to the partly fibrous, non-contractile left ventricular outflow. Obstruction to RV ejec-
tion might be expected to impede flow from the RV to PA and cause right heart failure:
decreased cardiac output and increased right heart filling pressures.
We recently presented data suggesting that a substantial number of patients without a rest-
ing RV-to-PA gradient develop a substantial pressure gradient across the RVOT during
upright exercise despite an absence of specific types of structural or congenital heart disease
[21]. Whether such dynamic pressure gradients are associated with disadvantageous hemody-
namics, such as elevated right heart filling pressure or reduced cardiac output, are unknown.
The current study presents hemodynamic and metabolic characteristics corresponding to the
development of an RV-to-PA pressure gradient during exercise.
Methods
Study sample and design
We studied consecutive patients with unexplained exertional intolerance referred to the Dys-
pnea Clinic at Brigham and Women’s Hospital who underwent resting supine right heart cath-
eterization followed by upright invasive symptom-limited cardiopulmonary exercise testing
Exercise RVOT gradient hemodynamics
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between May 2012 and May 2015. We excluded patients without RV pressure tracings during
exercise (i.e., alternative catheter used or RV port located in right atrium [RA], n = 296) and
those with a supine resting RVOT gradient >10mmHg (n = 16, 6 with known pulmonary
valve stenosis). The Partners Human Research Committee approved this retrospective study
and waived the requirement for informed consent (protocol #2011P000272).
Right heart catheterization and exercise
Testing was performed as previously described [22]. A flow-directed, balloon-tipped, 4-port
pacing PA catheter (Swan-Ganz Pacing-TD Catheter, Edwards Lifesciences, Irvine, CA, USA)
was positioned into a branch PA and a radial artery line was also placed. Systemic arterial, RA,
RV, PA, and PA wedge (PAWP) pressures were measured with a hemodynamic monitoring
system (Xper Cardio Physiomonitoring System, Philips, Andover, MA, USA) calibrated before
each study. Pressure measurements were taken at the end of a passive exhalation; when respir-
ophasic variation persisted despite attempted passive exhalation, the electronic average over 3
respiratory cycles was used. The pressure transducer was leveled 5 cm below the axillary fold
in the mid axillary line. We repeated manual measurement of all hemodynamic tracings in a
subset (n = 17) for quality control. For PA systolic pressure at rest and at peak exercise,
r = 0.97 (bias = 2.4±3.0 mmHg) and r = 0.98 (bias = -0.4±3.9 mmHg), respectively. For RV sys-
tolic pressure, r = 0.97 (bias = -0.1±2.5 mmHg) and r = 0.96 (bias = -2.4±4.1 mmHg) at rest
and peak exercise, respectively.
All exercise tests were performed on an upright cycle ergometer with the patient breathing
room air. After 2 minutes of rest followed 3 minutes of unloaded cycling at 55–65 rpm, work
rate was then continuously increased until limited by symptoms. Breath-by-breath pulmonary
gas exchange and minute ventilation (VE) were measured using a commercially available meta-
bolic cart (Ultima CPX, MGC Diagnostics, St. Paul, MN, USA). VE, inspired and expired O2
and CO2 concentrations, heart rate, radial arterial pressure, RA pressure, RV pressure, and PA
pressure were measured continuously; PAWP was obtained at rest and once each minute of
exercise. RVOT gradient was calculated supine, upright at rest and upright at peak exercise as
the difference between RV and PA systolic pressures, measured simultaneously from the
respective catheter ports.
Statistical analysis
Categorical data are expressed as number with percentages, while continuous variables are
reported as mean±standard deviation or median [25th-75th percentile] as appropriate for dis-
tribution. The cohort was divided into 2 groups using a cutoff at the 90th percentile of RVOT
gradient at peak exercise (33mmHg). Receiver-operating characteristic (ROC) curves
were constructed to determine the diagnostic accuracy of systolic RV versus systolic PA pres-
sure to identify an abnormal PA pressures response, defined as peak mean PA pressure
(mPAP) >30mmHg [23, 24]. Optimal cut-points were identified using the Youden index. We
repeated this analysis using a more comprehensive definition of abnormal pulmonary vascular
response, peak mPAP>30mmHg and peak PVR>120 dynesseccm-5. Predicted peak VO2
was estimated using published equations[25]. Continuous variables were compared between
groups with the Student’s unpaired t-test for normally distributed variables and Mann-Whit-
ney U test for non-normally distributed variables. Categorical variables were compared
between groups using Fisher’s exact test. Pearson correlation analysis was performed to deter-
mine correlation between peak RVOT gradient and clinical and physiological variables. Multi-
variable linear regression, adjusting for age and sex, was used to identify independent
predictors of development of increased RVOT gradient. We used linear regression using
Exercise RVOT gradient hemodynamics
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stepwise selection (p-value <0.10 was set for both entry to and retention in the model) to iden-
tify key clinical, demographic, or resting hemodynamic variables predictive of peak RVOT gra-
dient. This procedure was repeated with the addition of peak exercise response variables using
the same model building approach. The variables considered for inclusion in these models are
listed in S1 Table.
Statistical analyses were performed using SPSS Statistics 23.0 (IBM, Chicago, IL, USA), SAS
9.3 (SAS Institute, Cary, NC, USA) and GraphPad Prism version 5.01 for Windows (GraphPad
Software, La Jolla, CA, USA). A 2-tailed P<0.05 was used as the criterion for statistical
significance.
Results
Demographics and clinical characteristics
The characteristics of the study sample are summarized in Table 1. There were 294 patients
included in the analysis, 49% male with mean age of 59.7±15.5 years. Hypertension (49%), dys-
lipidemia (43%) and obesity (37%, body mass index30 kg/m2) were common. Average peak
VO2 was 17.1±7.8 mL/kg/min, or 74.8±23.3% predicted. Peak respiratory exchange ratio aver-
aged 1.13, consistent with maximal exercise effort.
Dynamic RVOT gradient with upright posture and during exercise
Supine resting RVOT gradient was negligible (mean 1.6±3.6 mmHg, median 2 [-1-4]; 90th per-
centile 6 mmHg), but there was on average a modest systolic gradient between the RV and PA
at rest while upright (mean 8.8±5.5 mmHg, median 9 [5–12]; 90th percentile 16 mmHg). At
peak exercise, the average RVOT gradient was 18.7±11.2 mmHg (median 18 [11–25]; 90th per-
centile 33 mmHg). Peak exercise RVOT gradient was only modestly correlated with supine
resting RVOT gradient (r2 = 0.14, p<0.001; Fig 1A), upright resting RVOT gradient (r2 = 0.24,
p<0.001; Fig 1B), and change in resting RVOT gradient from the supine to upright position
(r2 = 0.11, p<0.001; Fig 1C). Neither supine RVOT gradient nor change in gradient with posi-
tion was independently associated with peak exercise gradient after adjustment for upright
resting gradient.
Among patients with a peak RVOT gradient at or above the 90th percentile (33 mmHg,
referred to as a high RVOT gradient, n = 33), the mean gradient was 39.1±6.7 mmHg at peak
exercise, while it averaged 16.1±8.7 mmHg among the other 261 patients (Table 1). Patients
with a high RVOT gradient were younger (43.6±17.7 vs. 61.8±13.9 years, p<0.001), more likely
to be male (70% vs. 46%, p = 0.01) and had lower body mass index (25.9±4.8 vs. 29.3±6.6 kg/
m2, p = 0.004) than those with peak RVOT gradient <33 mmHg. To provide a better under-
standing of differences in baseline characteristics independent of the important differences in
sex and age, we used linear regression to adjust for these variables. While those with high
RVOT gradients were also taller with higher forced expiratory volume in 1 second and hemo-
globin concentration, had higher peak RER, were less likely to have hypertension or diabetes
mellitus, and less likely to be taking cardiovascular medications, these associations appeared to
be related to the different age and sex distribution between groups (Table 1, right column).
Resting hemodynamics
Hemodynamic data at upright rest and peak exercise are presented in Table 2. Patients with a
high exercise RVOT gradient had higher resting cardiac index (3.1±0.9 vs. 2.5±0.8 L/min/m2,
p<0.001) in the context of higher stroke volume (84±36 vs. 68±24 mL, p<0.001), and similar
heart rate (p = 0.48)(Fig 2). The higher cardiac index and stroke volume were accounted for by
Exercise RVOT gradient hemodynamics
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Table 1. Demographic and clinical characteristics of the study sample.
Total
n = 294
RVOT gradient at peak, stratified by: p value adjusted
p value*< 33 mmHg
n = 261
 33 mmHg
n = 33
Demographics and anthropometrics
Male sex 144 (49) 121 (46) 23 (70) 0.01 -
Age [years] 59.7±15.5 61.8±13.9 43.6±17.7 <0.001 -
Height [cm] 171.3±9.9 170.5±9.8 176.9±9.5 <0.001 0.29
Weight [kg] 85.1±21.1 85.6±21.7 81.1±16.0 0.26 0.06
BSA [m2] 1.97±0.25 1.96±0.26 1.98±0.21 0.79 0.16
BMI [kg/m2] 29.0±6.5 29.3±6.6 25.9±4.8 0.004 0.02
Clinical characteristics
Hemoglobin [g/dL] 13.8±1.9 13.6±1.8 15.0±1.5 <0.001 0.05
FEV1 [% predicted] 82.2±21.8 80.8±22.0 93.2±17.6 0.002 0.07
FVC [% predicted] 83.3±20.3 81.9±20.2 94.3±18.1 0.001 0.09
FEV1 / FVC 0.77±0.1 0.76±0.1 0.8±0.08 0.04 0.54
Peak Work rate [W] 108±83 99±80 179±71 <0.001 0.21
Peak RER 1.13±0.13 1.12±0.13 1.2±0.09 0.001 0.14
Peak VO2 [% predicted] 74.8±23.3 72.6±20.7 92.4±33.8 0.002 <0.001
Peak VO2 [ml/kg/min] 17.1±7.8 15.8±6.4 27.2±9.8 <0.001 <0.001
Cardiovascular risk factors and history
Hypertension 143 (49) 136 (52) 7 (21) 0.001 0.22
Dyslipidemia 125 (43) 117 (45) 8 (24) 0.02 0.68
Diabetes mellitus 42 (14) 41 (16) 1 (3) 0.06 0.25
Current tobacco use 3 (1) 3 (1) 0 1.00 1.00
CABG 21 (7) 21 (8) 0 0.15 1.00
PCI 33 (11) 33 (13) 0 0.04 1.00
Valvular disease 30 (10) 28 (11) 2 (6) 0.55 0.82
Medication
Acetylsalicylic acid 95 (32) 91 (35) 4 (12) 0.01 0.21
Diuretic 89 (30) 85 (33) 4 (12) 0.02 0.44
Beta blocker 88 (30) 84 (32) 4 (12) 0.02 0.54
ACE inhibitor or ARB 59 (20) 57 (22) 2 (6) 0.03 0.12
Calcium channel blocker 54 (18) 51 (20) 3 (9) 0.14 0.48
Diagnosis**
Exercise HFpEF 40 (14) 39 (15) 1 (3) 0.06 0.17
Exercise pulmonary hypertension 76 (26) 75 (29) 1 (3) <0.01 0.06
Isolated low venous filling pressures 59 (20) 44 (17) 15 (45) <0.01 0.09
Impaired peripheral oxygen extraction 35 (12) 31 (12) 4 (12) 1.0 0.60
Demographic and clinical characteristics for the overall study cohort and stratified by the 90th percentile of peak right ventricular outflow tract (RVOT)
gradient, 33 mmHg. Data are presented as mean ± SD or n (%). Data on age, sex, and peak VO2 for those with and without an RVOT gradient, as well as
BMI and the prevalence of hypertension, dyslipidemia, CABG, PCI and beta-blocker use in the overall cohort have been previously published.[21]
*Multivariable logistic regression, adjusted for age and sex.
**Primary diagnosis based on invasive cardiopulmonary exercise test findings in the context of other clinical data. The most common primary
hemodynamic diagnoses are provided; less frequent diagnoses, some of which may exist in conjunction with the primary diagnoses listed, are not
presented including a pulmonary mechanical limit, chronotropic incompetence, heart failure with reduced ejection fraction, hyperventilation, systemic
hypoxemia, and anemia. Likewise omitted are patients with mixed disease (e.g., peak pulmonary capillary wedge pressure >20mmHg and also peak
pulmonary vascular resistance >160 dynes.s.cm-5). Isolated low venous filling pressure was defined as peak right atrial pressure <6mmHg in the absence of
another listed diagnosis. Other diagnoses are defined as described elsewhere [22].
ACE—angiotensin-converting enzyme; ARB—angiotensin receptor blocker; BMI—body mass index; BSA—body surface area; CABG—coronary artery
bypass graft; FEV1 —forced expiratory volume in 1 second; FVC—forced vital capacity; HFpEF—heart failure with preserved ejection fraction; PCI—
percutaneous coronary intervention; RER—respiratory exchange rate.
https://doi.org/10.1371/journal.pone.0179053.t001
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the underlying differences in age and sex (linear regression adjusting for age and sex presented
in the right most column of Table 2). Resting right atrial pressure was lower in those who
developed high exercise RVOT gradient (median 0 [IQR 0–4] vs. 3 [IQR 1–6] mmHg), as was
PAWP (median 4 [IQR 3–8] vs. 8 [IQR 5–11] mmHg) (p<0.001 for both). Resting pulmonary
pressure was also lower at rest (mPAP 12.3±3.6 vs. 18.0±7.4 mmHg, p<0.001), due to both
lower PAWP and lower pulmonary vascular resistance (100±40 vs. 172±98 dynesscm-5,
p<0.001). There was no statistically significant difference between groups in resting systolic
RV pressure (p = 0.39).
Hemodynamics at peak exercise
The hemodynamic pattern at peak exercise was largely, though not entirely, similar to the rest-
ing findings. Those with high exercise RVOT gradient had higher peak cardiac index (8.3±2.3
vs. 5.7±1.9 L/min/m2, p<0.001), in the context of both higher peak heart rate (159±19 vs. 124
±26 bpm, p = 0.001) and stroke volume (104±25 vs. 91±26 mL/beat, p<0.001). The higher
stroke volume was related to differences in age and sex, while the relationship between higher
heart rate and higher RVOT gradient persisted after adjustment for these covariates (Table 2).
Furthermore, both RA pressure and PAWP remained significantly lower during exercise in
the high RVOT gradient group, as did pulmonary vascular resistance. Importantly, mPAP
remained lower in the high RVOT gradient group at peak exercise and there was no difference
between those who did and did not develop a high RVOT gradient in the change in mPAP
during exercise (+13.8±4.7 vs. +15.4±8.1 mmHg, p = 0.11). RV systolic pressure increased by
45.6±11.4 mmHg in patients with high RVOT gradient, but only 32.0±11.9 mmHg for the
patients with RVOT gradient <33mmHg at peak exercise (p<0.001).
Multivariable predictors of higher RVOT gradient
Multivariable linear regression identified several resting/baseline predictors of peak RVOT
gradient (Table 3, top section). The predictors which correlated most strongly with increased
peak exercise RVOT gradient included lower resting mPAP, younger age, and male sex. Other
variables associated with higher gradient were higher resting systolic blood pressure, not tak-
ing a beta-blocker medication, higher forced vital capacity, and higher resting heart rate.
When peak hemodynamic and other exercise variables were considered in addition to the
resting/baseline data, model performance improved and the strongest correlates of higher
Fig 1. Relationships between supine and upright resting right ventricular outflow tract (RVOT) gradient and peak exercise RVOT gradient.
Scatterplots of peak RVOT pressure gradient (i.e., RVSP-PASP) versus supine resting RVOT gradient (Panel A), upright resting RVOT gradient
(Panel B), and the change in RVOT pressure gradient between from supine to upright positions at rest (Panel C). In the small subset of cases where
resting RVSP-PASP was negative, the gradient was set to 0 mmHg. PASP—pulmonary artery systolic pressure; RVSP—right ventricular systolic
pressure.
https://doi.org/10.1371/journal.pone.0179053.g001
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Table 2. Association between resting and exercise hemodynamic variables a with peak RVOT gradient during upright cycle ergometry.
Total
n = 294
Peak RVOT gradient, stratified Peak RVOT gradient, continuous
< 33 mmHg
n = 261
 33 mmHg
n = 33
p value Univariate Multivariate*
β p value p value
Resting hemodynamics, upright
Systolic BP [mmHg] 146±23 146±24 145±20 0.8 0.02 0.59 0.007
Diastolic BP [mmHg] 79±13 78±13 81±11 0.18 0.16 0.002 0.09
Stroke volume [mL] 69.2±26.1 67.6±24.4 84.1±35.5 0.001 0.04 0.09 0.7
Heart rate [bpm] 75±14 75±13 77±20 0.48 0.08 0.09 0.1
Cardiac output [L/min] 5.0±1.7 4.9±1.6 6.2±1.8 <0.001 1.09 0.005 0.97
Cardiac index [L/min/m2] 2.6±0.8 2.5±0.8 3.1±0.9 <0.001 2.24 0.004 0.54
Right atrial pressure [mmHg] 3 [0–6] 3 [1–6] 0 [0–4] <0.001 -1.09 <0.001 <0.001
PCW pressure [mmHg] 7 [4–11] 8 [5–11] 4 [3–8] <0.001 -0.82 <0.001 <0.001
Mean PA pressure [mmHg] 17.3±7.3 18±7.4 12.3±3.6 <0.001 -0.64 <0.001 <0.001
Systolic PA pressure [mmHg] 25±11.3 25.9±11.6 18.0±5.2 <0.001 -0.38 <0.001 <0.001
Systolic RV pressure [mmHg] 33.8±10.8 34±11.1 32.2±8.1 0.39 -0.16 0.009 0.18
PVR [dynes.s.cm-5] 164±96 172±98 100±40 <0.001 -0.03 <0.001 0.03
RVOT gradient [mmHg] 8.8±5.5 8.1±5.1 14.3±6.2 <0.001 1.01 <0.001 <0.001
Peak exercise hemodynamics
Systolic BP [mmHg] 180±38 179±37 184±45 0.48 0.06 0.001 0.003
Diastolic BP [mmHg] 82±18 82±17 86±20 0.17 0.14 <0.001 0.33
Stroke volume [mL] 92.6±25.8 91.4±25.7 103.7±24.5 0.02 0.08 0.003 0.99
Heart rate [bpm] 128±28 124±26 159±19 <0.001 0.24 <0.001 <0.001
Cardiac output [L/min] 11.8±4.3 11.3±3.9 16.6±4.4 <0.001 1.29 <0.001 <0.001
Cardiac index [L/min/m2] 6±2 5.7±1.9 8.3±2.3 <0.001 2.91 <0.001 <0.001
Right atrial pressure [mmHg] 7 [4–11] 8 [4–12] 5 [3–7] <0.001 -0.57 <0.001 <0.001
PCW pressure [mmHg] 14 [10–20] 14 [10–21] 12 [10–15] 0.04 -0.37 <0.001 0.001
Mean PA pressure [mmHg] 32.5±11.9 33.3±12.2 26.1±5.9 <0.001 -0.34 <0.001 <0.001
Systolic PA pressure [mmHg] 48.7±18.1 50±18.7 38.8±7.6 <0.001 -0.25 <0.001 <0.001
Systolic RV pressure [mmHg] 67.3±17.1 66±17.4 77.9±10.7 <0.001 0.15 <0.001 <0.001
PVR [dynes.s.cm-5] 134±98 140±101 78±41 <0.001 -0.04 <0.001 <0.001
RVOT gradient [mmHg] 18.7±11.2 16.1±8.7 39.1±6.7 <0.001 - - -
Change, rest to peak exercise
Stroke volume [mL] 23.3±24.9 23.7±23.9 19.5±33.2 <0.001 0.04 0.18 0.72
Heart rate [bpm] 53±26 49±24 82±20 0.41 0.26 <0.001 <0.001
Cardiac output [L/min] 6.8±3.8 6.4±3.5 10.4±4.2 <0.001 1.45 <0.001 <0.001
Cardiac index [L/min/m2] 3.4±1.8 3.2±1.7 5.2±2.2 <0.001 3.1 <0.001 <0.001
Right atrial pressure [mmHg] 4 [1–7] 4 [1–7] 3 [0–5] 0.13 -0.47 0.001 0.003
PCW pressure [mmHg] 7 [4–10] 7 [3–11] 7 [4–10] 0.51 -0.02 0.87 0.63
Mean PA pressure [mmHg] 15.2±7.8 15.4±8.1 13.8±4.7 0.11 -0.23 0.006 0.002
Systolic PA pressure [mmHg] 23.7±11.0 24.1±11.4 20.8±7.3 0.03 -0.26 <0.001 <0.001
Systolic RV pressure [mmHg] 33.5±12.6 32±11.9 45.6±11.4 <0.001 0.4 <0.001 <0.001
RVOT gradient [mmHg] 9.8±9.9 7.9±8.2 24.8±9.4 <0.001 0.98 <0.001 <0.001
Hemodynamic variables at rest, peak exercise, and change between rest and peak exercise are presented for the whole cohort and stratified according to
the 90th percentile of peak RVOT gradient, 33mmHg. Data are presented as mean ± SD or median [25th– 75th percentile] as appropriate for distribution.
Univariate linear regression coefficients are presented. The upright resting and peak RVOT gradients for the overall cohort (8.8 ± 5.5 mm Hg and
18.7 ± 11.2 mm Hg, respectively) have been published previously [21].
*Multivariable linear regression, adjusted for age and sex.
BP—blood pressure; PA—pulmonary artery; PCW—pulmonary capillary wedge pressure; PVR—pulmonary vascular resistance; RV—right ventricle;
RVOT—right ventricular outflow tract.
https://doi.org/10.1371/journal.pone.0179053.t002
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peak RVOT gradient were higher peak heart rate and lower peak mPAP (Table 3, bottom sec-
tion). Several other variables, including peak cardiac output and right atrial pressure, were
only weakly predictive of peak RVOT gradient after multivariable adjustment. Higher hemo-
globin concentration as well as both higher systolic and lower resting diastolic resting blood
pressure, were also associated with higher peak RVOT gradient, albeit quite modestly. As
Fig 2. Association between selected exercise hemodynamic variables and right ventricular outflow tract (RVOT) systolic pressure
gradient at peak exercise. Scatterplots showing the relationship of various peak exercise hemodynamic variables with RVOT systolic
pressure gradient at peak exercise. The best-fit linear regression line is plotted with 95% confidence intervals. Panel A—Peak cardiac index
versus peak RVOT gradient; Panel B—Peak RAP versus peak RVOT gradient; Panel C—Peak stroke volume versus peak RVOT gradient;
Panel D—Peak heart rate versus peak RVOT gradient. RAP—right atrial pressure; RVOT—right ventricular outflow tract.
https://doi.org/10.1371/journal.pone.0179053.g002
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importantly, when exercise variables were considered neither age nor sex remained an inde-
pendent predictor of RVOT gradient.
Sensitivity analyses
There was no apparent heterogeneity among demographic, hemodynamic or diagnostic sub-
groups in terms of the positive relationship between higher RVOT gradient at peak exercise
and greater peak VO2. These analyses included stratification by sex, age (by median value),
peak RAP (< vs.7mmHg), peak PAWP (< vs.21mmHg), peak arterial-venous O2 content
difference (< vs90% of resting hemoglobin concentration), peak heart rate (< vs85% pre-
dicted peak heart rate) and body mass index (< vs.26 kg/m2). We further assessed for 2-way
interaction between peak RVOT gradient and each of these variables, as both continuous and
categorical variables. There were no statistically significant 2-way interactions. That is, there
Table 3. Multivariable predictors of peak RVOT gradient during upright cycle ergometry.
Baseline/Resting Variables Alone
Variable β coefficient P value Partial r2
Mean PAP, upright -0.48 <.0001 0.102
Age -0.19 <.0001 0.086
Sex, male 4.69 <.0001 0.071
SBP, rest 0.08 0.0004 0.046
Taking beta-blocker -4.15 0.0008 0.042
FVC, % predicted 0.08 0.01 0.025
Heart rate, rest 0.07 0.06 0.013
Baseline/Resting Plus Peak Exercise Variables
Variable β coefficient P value Partial r2
Peak HR 0.17 <.0001 0.164
mPAP, peak -0.37 <.0001 0.153
Cardiac output, peak 0.46 0.003 0.037
SBP, rest 0.09 0.003 0.036
PAWP, peak 0.31 0.003 0.036
[Hgb] 0.81 0.009 0.028
RAP, peak -0.28 0.02 0.023
DBP, rest -0.12 0.03 0.018
Top: A multivariable model of baseline predictors of the magnitude of RVOT pressure gradient with exercise,
continuous variable per mmHg. Variable selection was performed in a stepwise manner, with a p-value <0.1
required for both entry and retention in the model.
Use of a simpler forward selection approach with p for entry <0.1 resulted in inclusion of the same variables,
but with the addition of hemoglobin concentration in the model (for hemoglobin concentration, final p = 0.16
and partial r2 = 0.007).
Bottom: A multivariable model of independent correlates of development of an RVOT pressure gradient with
exercise, including both baseline/resting data and peak exercise variables. The same approach to model
selection was applied as for the resting model. Use of a simpler forward selection approach with p for entry
<0.1 produced the same result.
Variables considered for inclusion in both models are listed in S1 Table. Type II partial Pearson correlation
coefficients are also presented.
BPM—beats per minute; FVC—forced vital capacity; [Hgb]—hemoglobin concentration; PAWP—pulmonary
artery wedge pressure; mPAP—mean pulmonary artery pressure; PVR—pulmonary vascular resistance;
RAP—right atrial pressure; S/DBP—systolic/diastolic blood pressure.
https://doi.org/10.1371/journal.pone.0179053.t003
Exercise RVOT gradient hemodynamics
PLOS ONE | https://doi.org/10.1371/journal.pone.0179053 June 21, 2017 9 / 17
was no indication that higher RVOT gradient may be related to worse aerobic capacity in any
subset.
Relationship between pulmonary artery and right ventricular pressure
response
As noted in our prior report [21], there was a close relationship between invasively measured
systolic and mean PA pressure at peak exercise (r2 = 0.88, Fig 3A). Due to the presence of a var-
iable pressure gradient across the RVOT during exercise, RV systolic pressure systematically
overestimated systolic PA pressure or mean PA pressure (r2 = 0.63 and r2 = 0.57, respectively;
Fig 3B and 3C). Half (n = 147) of the patients demonstrated an abnormal pulmonary pressure
response during exercise, defined as peak mPAP >30 mmHg. Almost all patients with a
hypertensive pulmonary pressure response also had elevated RV systolic pressure (99%,
n = 145/147 >50mmHg). However, many patients with normal exercise PA pressure also
had elevated RV systolic pressure at peak exercise (>50mmHg in 75%, >60mmHg in 37%,
and>70mmHg in 15.6%).
Receiver operating characteristic analysis identified optimal cutoff points for RV systolic
pressure and PA systolic pressure for an abnormal pulmonary pressure response during
exercise (mPAP>30 mmHg). PA systolic pressure >43 mmHg provided sensitivity and
specificity of 93% and 84%, respectively, to identify abnormal mPAP response (AUC = 0.97,
95% CI 0.95–0.98) (Fig 4, blue dashed-dotted line). Systolic RV pressure was less predictive; a
value >61 mmHg had sensitivity and specificity of 84% and 63%, respectively (AUC = 0.82,
95% CI 0.77–0.87)(Fig 4, red solid line). To provide context, both resting supine right heart
catheterization PA systolic and RV systolic pressures (Fig 4, AUC = 0.86 and 0.83, respectively)
were at least as predictive of abnormally elevated peak exercise mPAP. Both PA and RV sys-
tolic pressure were modestly less predictive when a more comprehensive definition of abnor-
mal pulmonary vascular response was used (peak mPAP>30mmHg and peak PVR>120
dynesseccm-5, n = 82); for PA systolic pressure and RV systolic pressure, AUC were 0.92 and
0.76, respectively.
Discussion
We recently reported that a subset of patients referred for invasive evaluation of effort intoler-
ance develop a pressure gradient across the RVOT during upright exercise, despite the absence
of a resting gradient or known anatomic reason for dynamic obstruction [21]. That brief
report, from the same cohort included in the present analysis, noted that the presence of an
RVOT gradient was more common in younger, male patients and was associated with higher
peak VO2. The current paper further describes clinical, hemodynamic and metabolic features
associated with the development of such a gradient. Most importantly, the existence of an exer-
cise RVOT gradient was not accompanied by clinical or hemodynamic features of right heart
failure. In fact, the converse was seen: a high RVOT gradient during exercise was associated
with low biventricular filling pressures, more robust cardiac output response, and higher peak
VO2. These findings suggest that a pressure difference between the RV and PA may represent
a newly appreciated but possibly normal hemodynamic response to exercise in well-condi-
tioned young people. Confirmation of that hypothesis will require validation in independent
cohorts of healthy people.
We can only speculate as to a possible functional reason for the finding described based on
the available data. The RVOT, or infundibulum, is anatomically and embryologically distinct
from the main body of the RV, as described by Arthur Keith in 1924 [26]. Sir Keith also
hypothesized a function for the RVOT in normal humans: “the safeguarding of the capillary
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system of the lungs from high and prolonged accessions of blood pressure”, as would be seen
during periods of exertion or stress [26]. This would parallel the function of the bulbus cordis
in lower vertebrates. Alternatively, elevated RV systolic pressure at high levels of exercise may
help preserve advantageous ventricular interaction (e.g., prevent collapse of the RV inflow,
which could impede right-sided early diastolic filling) when left ventricular systolic pressure is
markedly elevated. It is also possible that this finding is simply an epiphenomenon, the logical
extreme consequence of left ventricular and septal contribution to RV contraction.
The RVOT has distinct contraction patterns and responses to inotropic agents [27]. Under
normal conditions, the infundibulum contracts ~20–50 msec after the body of the RV and
maintains contraction into diastole [28–30]. Sympathetic stimulation or norepinephrine injec-
tion can suppress this delay [31]. One might hypothesize that the infundibulum’s catechol-
amine response protects the pulmonary vasculature from high pressure during episodes of
extreme exertion while maintaining advantageous peristaltic contraction. Keith’s early 20th-
century hypothesis and more recent physiologic observations, therefore, are consistent with
our findings that a dynamic RVOT gradient occurs more frequently in the presence of high
cardiac output. On the other hand, this observation could simply reflect higher flow across a
similar anatomic obstruction. RVOT anatomy (relatively long and narrow) would seem to pre-
dispose to such a response. A flow-based mechanism alone, though, could not explain the
increase in gradient from supine to upright position, since cardiac output is lower in the
upright compared with supine position [32]. The slow frequency response of a fluid filled cath-
eter precludes comment on the timing of gradient during systole. Clarification of the underly-
ing mechanism of the observed RVOT gradient will require more detailed investigation.
Whatever the underlying causes and consequences of dynamic RVOT obstruction with
exercise, this finding has implications for the use of echocardiography to quantify pulmonary
pressure response during exercise. The current data suggest echocardiography would substan-
tially overestimate pulmonary artery systolic pressure in a subset of patients. This concern,
though, may be more relevant when screening lower risk populations; there was a low preva-
lence of exercise pulmonary hypertension among patients with high RVOT gradients. Studies
Fig 3. Relationships between peak right ventricular systolic and pulmonary artery systolic and mean pressures at peak exercise. (Panel
A) Scatterplot showing the close correspondence of invasively measured peak exercise systolic pulmonary artery (PA) pressure and mean PA
pressure. (Panel B) Scatterplot of invasively measured peak exercise systolic right ventricular (RV) pressure against peak exercise systolic PA
pressure. Peak RV systolic pressure is systematically higher than peak PA systolic pressure. Also, the correlation between RV and PA systolic
pressures is less robust than would be expected. (Panel C) As a result of the systematic but variable RV-to-PA systolic pressure gradient, the
relationship between peak systolic RV pressure and peak mean PA pressure is only moderately strong. For all panels, the solid black line
represents the best-fit regression line with dotted lines representing 95% prediction limits. The dashed red line in panel B signifies identity (x = y).
PA- pulmonary artery; RV- right ventricle.
https://doi.org/10.1371/journal.pone.0179053.g003
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have shown that assessment of the pulmonary circulation during exercise can identify early or
latent pulmonary vascular disease in patients at risk of developing pulmonary hypertension
[10, 12, 33]. It may also help define underlying pathophysiology among patients with high-
normal pulmonary artery pressure, who are at increased risk for adverse outcomes [34]. An
abnormal pulmonary vascular response during exercise has furthermore been associated with
decreased exercise capacity and development of resting pulmonary arterial hypertension,
highlighting the clinical importance of ‘exercise-induced’ pulmonary hypertension and the
possible role for noninvasive screening in high-risk patient subgroups [35–38].
Of note, while high RVOT gradients during exercise were not associated with a clear patho-
logic finding in terms of usual definitions of cardiovascular dysfunction (i.e., higher filling
pressure, lower cardiac index, lower VO2), the subjects studied were referred because of exer-
tional symptoms. In that context, it is possible that such high RVOT gradients may play a path-
ologic role in specific patient groups, as has been described in those recovering from cardiac
surgery [1]. Patients with low venous pressure during exercise were prone to develop high
RVOT gradients. Dynamic RVOT obstruction could presumably be part of the mechanism of
symptoms in such patients [39], as it may in a subset of patients with hypertrophic cardiomy-
opathy [40]. This could help explain the divergent response of such patients to pharmacologic
Fig 4. Receiver operating characteristic curve analysis of resting and peak exercise right heart pressures to identify peak
exercise mean pulmonary artery pressure >30 mmHg. Peak exercise PA systolic pressure is able dependably to identify patients
with abnormally high mean PA pressure at peak exercise (AUC 0.97, blue dotted-dashed line). Peak exercise RVSP is less well able
to discriminate between normal and elevated exercise mean PA pressure (AUC 0.82, red solid line). Resting supine right heart
catheterization RV systolic pressure (AUC 0.83, brown dashed double-dotted line) and PA systolic pressures (AUC 0.86, green
dashed line) each provided similar or slightly better discrimination between normal and elevated exercise PA pressure. PA—
pulmonary artery; PASP—pulmonary artery systolic pressure; RV—right ventricle; RVSP—right ventricle systolic pressure.
https://doi.org/10.1371/journal.pone.0179053.g004
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agents (e.g., beta-blockers). Patients for whom RVOT obstruction is playing a role may selec-
tively benefit from these medications. These remain speculative hypotheses; we were unable to
identify any subset of patients where higher RVOT gradient was associated with lower aerobic
capacity. This could, however, be due to limited subgroup sample size or confounding mecha-
nisms underlying symptoms. It will be necessary to study normal, asymptomatic individuals to
better understand whether it is truly normal to develop a dynamic pressure gradient across the
RVOT.
We did not perform a direct comparison of invasive measurement and echocardiographic
estimation of the PA pressure, but precise invasive measurement of RV systolic pressure
should be the best possible scenario for the use of Doppler tricuspid regurgitant systolic veloc-
ity to estimate PA systolic pressure. Moreover, while using mPAP>30mmHg is not a compre-
hensive definition of abnormal exercise pulmonary vascular response, this approach only
favors RV systolic pressure, whether invasive or non-invasive. Of note, though these findings
strongly imply that upright exercise echocardiographic estimation of PA systolic pressure
would be non-specific, echocardiography is able to provide a more nuanced and comprehen-
sive view of pulmonary vascular physiology including estimates of resistance [41, 42].
These results must be interpreted within the limitations intrinsic to the study design. Most
fundamentally, the study sample was comprised of symptomatic patients with heterogeneous
pathophysiology. This limits inference about whether the findings described may be normal, a
normal variant, a beneficial physiologic response to high flow, or a novel pathophysiologic
underpinning of dyspnea in a discrete set of patients. The spectrum of underlying disease is
also particular to this setting, both because of institutional referral patterns and since invasive
exercise testing is usually reserved for situations where non-invasive and resting invasive test-
ing are insufficient. This would tend to enrich the study sample for patients with difficult to
diagnose conditions such as disorders of oxygen extraction (e.g., mitochondrial disorders),
exercise pulmonary hypertension, and isolated impairment of venous return. These biases do
not threaten the fundamental validity of our observations, but do limit their generalizability.
That is, the prevalence and magnitude and relevance of exercise RVOT gradients in the general
population cannot be inferred from the available data. We also cannot entirely exclude the pos-
sibility that the gradient described is artifactual. One could propose, for example, there may be
selective ring artifact (overshoot) for the RV port/lumen but not the PA or RA port/lumens
related to the higher frequency components of RV pressure. Alternatively, one could hypothe-
size a local pressure effect of contracting RV muscle bundles. Artifact, however, seems unlikely
to explain our findings for a number of reasons. First, an RVOT gradient was never seen dur-
ing supine rest but was present during upright rest and with exercise in a subset of patients.
One would expect the conditions that create the artifact to be present in at least a small number
of patients in the supine position. Second, the finding was consistent; there was never a
reversed gradient with PA pressure being substantially higher than RV pressure. Third, RV
diastolic pressures were not affected. Fourth, prior studies using this catheter in supine animals
and humans have not reported the presence of a systolic pressure difference between the RV
and PA, [43, 44] while others have reported in post-operative patients a similar phenomenon
(in that context, however, it was associated with reduced cardiac output) that was reversible by
medical intervention [1, 44]. Sex and body size were associated with RVOT gradient severity.
It is plausible that the RV port is located more distally (i.e., in the RVOT distal to any obstruc-
tion) in larger patients. This, however, would bias towards a lower mean RVOT gradient in tal-
ler patients, the converse of what was seen. Finally, it remains unknown whether such an
RVOT gradient occurs during supine or semi-supine exercise. Further study is required to
define whether these findings have any direct ramifications for standard clinical stress echocar-
diography, which is usually performed supine. If this phenomenon is limited to exercise in the
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upright position, however, it adds to the list of fundamental positional differences in physio-
logic exercise response; since most day-to-day physical work is performed while upright, this
implies supine exercise testing may be suboptimal.
Conclusion
The development of a pressure gradient between the RV and PA during upright exercise does
not appear to be associated with an adverse hemodynamic profile. Further investigation is
needed to determine whether the finding described is due to normal physiology or represents
a specific pathophenotype among patients with unexplained effort intolerance. In either case,
however, these findings raise questions about the application during exercise of echocardio-
graphic methods commonly used to estimate systolic pulmonary artery pressure.
Supporting information
S1 Table. Variables considered for inclusion in the linear regression model. Top: A list of
variables considered for inclusion in a multivariable model to indicate independent resting
predictors of development of an RVOT pressure gradient with exercise. Variable selection was
performed in a stepwise manner, with p value <0.1 required for entry and retention in the
model. We selected a subset of variables among those that were highly correlated or mathemat-
ically related (e.g., resting upright systolic, mean and diastolic PA pressure; resting supine and
upright systolic PA pressure; PVR, transpulmonary gradient, PAWP and cardiac output). Var-
iables that could define resting upright RV pressure gradient were also omitted from consider-
ation (i.e., upright right ventricular and pulmonary artery systolic pressure).
Use of a simpler forward selection approach with p for entry <0.1 resulted in inclusion of the
same variables, but with the addition of hemoglobin concentration in the model (for hemoglo-
bin concentration, final p = 0.16 and partial r2 = 0.007).
Bottom: A list of variables considered, in addition to all resting data listed, for inclusion in a
multivariable model to indicate independent correlates of development of an RVOT pressure
gradient with exercise. Use of a simpler forward selection approach with p for entry<0.1
resulted in the same final model.
ACE—angiotensin converting enzyme; ARB—angiotensin receptor blocker; BMI—body mass
index; BSA—body surface area; CABG—coronary artery bypass graft; FEV1 —forced expira-
tory volume in 1 second; FVC—forced vital capacity; PCI—percutaneous coronary interven-
tion; PAWP—pulmonary artery wedge pressure; PA—pulmonary artery; PVR—pulmonary
vascular resistance.
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